162 related articles for article (PubMed ID: 32592722)
1. TNF-α inhibition decreases MMP-2 activity, reactive oxygen species formation and improves hypertensive vascular hypertrophy independent of its effects on blood pressure.
Mattos BR; Bonacio GF; Vitorino TR; Garcia VT; Amaral JH; Dellalibera-Joviliano R; Franca SC; Tanus-Santos JE; Rizzi E
Biochem Pharmacol; 2020 Oct; 180():114121. PubMed ID: 32592722
[TBL] [Abstract][Full Text] [Related]
2. β1-Adrenergic blockers exert antioxidant effects, reduce matrix metalloproteinase activity, and improve renovascular hypertension-induced cardiac hypertrophy.
Rizzi E; Guimaraes DA; Ceron CS; Prado CM; Pinheiro LC; Martins-Oliveira A; Gerlach RF; Tanus-Santos JE
Free Radic Biol Med; 2014 Aug; 73():308-17. PubMed ID: 24933619
[TBL] [Abstract][Full Text] [Related]
3. Comparative study on antioxidant effects and vascular matrix metalloproteinase-2 downregulation by dihydropyridines in renovascular hypertension.
Marçal DM; Rizzi E; Martins-Oliveira A; Ceron CS; Guimaraes DA; Gerlach RF; Tanus-Santos JE
Naunyn Schmiedebergs Arch Pharmacol; 2011 Jan; 383(1):35-44. PubMed ID: 21058008
[TBL] [Abstract][Full Text] [Related]
4. Time course involvement of matrix metalloproteinases in the vascular alterations of renovascular hypertension.
Ceron CS; Rizzi E; Guimaraes DA; Martins-Oliveira A; Cau SB; Ramos J; Gerlach RF; Tanus-Santos JE
Matrix Biol; 2012 May; 31(4):261-70. PubMed ID: 22342460
[TBL] [Abstract][Full Text] [Related]
5. Temporal changes in cardiac matrix metalloproteinase activity, oxidative stress, and TGF-β in renovascular hypertension-induced cardiac hypertrophy.
Rizzi E; Ceron CS; Guimaraes DA; Prado CM; Rossi MA; Gerlach RF; Tanus-Santos JE
Exp Mol Pathol; 2013 Feb; 94(1):1-9. PubMed ID: 23073243
[TBL] [Abstract][Full Text] [Related]
6. Nebivolol attenuates prooxidant and profibrotic mechanisms involving TGF-β and MMPs, and decreases vascular remodeling in renovascular hypertension.
Ceron CS; Rizzi E; Guimarães DA; Martins-Oliveira A; Gerlach RF; Tanus-Santos JE
Free Radic Biol Med; 2013 Dec; 65():47-56. PubMed ID: 23806385
[TBL] [Abstract][Full Text] [Related]
7. Pyrrolidine dithiocarbamate down-regulates vascular matrix metalloproteinases and ameliorates vascular dysfunction and remodelling in renovascular hypertension.
Cau SB; Guimaraes DA; Rizzi E; Ceron CS; Souza LL; Tirapelli CR; Gerlach RF; Tanus-Santos JE
Br J Pharmacol; 2011 Sep; 164(2):372-81. PubMed ID: 21434884
[TBL] [Abstract][Full Text] [Related]
8. Spironolactone and hydrochlorothiazide exert antioxidant effects and reduce vascular matrix metalloproteinase-2 activity and expression in a model of renovascular hypertension.
Ceron CS; Castro MM; Rizzi E; Montenegro MF; Fontana V; Salgado MC; Gerlach RF; Tanus-Santos JE
Br J Pharmacol; 2010 May; 160(1):77-87. PubMed ID: 20331602
[TBL] [Abstract][Full Text] [Related]
9. Antioxidant treatment reduces matrix metalloproteinase-2-induced vascular changes in renovascular hypertension.
Castro MM; Rizzi E; Rodrigues GJ; Ceron CS; Bendhack LM; Gerlach RF; Tanus-Santos JE
Free Radic Biol Med; 2009 May; 46(9):1298-307. PubMed ID: 19248829
[TBL] [Abstract][Full Text] [Related]
10. Doxycycline dose-dependently inhibits MMP-2-mediated vascular changes in 2K1C hypertension.
Guimaraes DA; Rizzi E; Ceron CS; Oliveira AM; Oliveira DM; Castro MM; Tirapelli CR; Gerlach RF; Tanus-Santos JE
Basic Clin Pharmacol Toxicol; 2011 May; 108(5):318-25. PubMed ID: 21176109
[TBL] [Abstract][Full Text] [Related]
11. Lercanidipine reduces matrix metalloproteinase-2 activity and reverses vascular dysfunction in renovascular hypertensive rats.
Martinez ML; Castro MM; Rizzi E; Fernandes K; Demacq C; Bendhack LM; Gerlach RF; Tanus-Santos JE
Eur J Pharmacol; 2008 Sep; 591(1-3):224-30. PubMed ID: 18634778
[TBL] [Abstract][Full Text] [Related]
12. Antihypertensive and vascular remodelling effects of the imperatorin derivative OW1 in renovascular hypertension rats.
Zhou N; Wang T; Song J; He H; He J; He L
Clin Exp Pharmacol Physiol; 2014 Aug; 41(8):571-8. PubMed ID: 24798462
[TBL] [Abstract][Full Text] [Related]
13. Doxycycline ameliorates 2K-1C hypertension-induced vascular dysfunction in rats by attenuating oxidative stress and improving nitric oxide bioavailability.
Castro MM; Rizzi E; Ceron CS; Guimaraes DA; Rodrigues GJ; Bendhack LM; Gerlach RF; Tanus-Santos JE
Nitric Oxide; 2012 Mar; 26(3):162-8. PubMed ID: 22327038
[TBL] [Abstract][Full Text] [Related]
14. Tempol inhibits TGF-β and MMPs upregulation and prevents cardiac hypertensive changes.
Rizzi E; Castro MM; Ceron CS; Neto-Neves EM; Prado CM; Rossi MA; Tanus-Santos JE; Gerlach RF
Int J Cardiol; 2013 Apr; 165(1):165-73. PubMed ID: 21917342
[TBL] [Abstract][Full Text] [Related]
15. Contrasting effects of aliskiren versus losartan on hypertensive vascular remodeling.
Martins-Oliveira A; Castro MM; Oliveira DM; Rizzi E; Ceron CS; Guimaraes D; Reis RI; Costa-Neto CM; Casarini DE; Ribeiro AA; Gerlach RF; Tanus-Santos JE
Int J Cardiol; 2013 Aug; 167(4):1199-205. PubMed ID: 22483258
[TBL] [Abstract][Full Text] [Related]
16. Antioxidant effect of doxycycline decreases MMP activity and blood pressure in SHR.
Antonio RC; Ceron CS; Rizzi E; Coelho EB; Tanus-Santos JE; Gerlach RF
Mol Cell Biochem; 2014 Jan; 386(1-2):99-105. PubMed ID: 24114660
[TBL] [Abstract][Full Text] [Related]
17. Antihypertensive Effects of
Hong MH; Jin XJ; Yoon JJ; Lee YJ; Oh HC; Lee HS; Kim HY; Kang DG
Nutrients; 2020 Oct; 12(11):. PubMed ID: 33138042
[No Abstract] [Full Text] [Related]
18. Losartan reduces monocyte chemoattractant protein-1 expression in aortic tissues of 2K1C hypertensive rats.
Xie QY; Sun M; Yang TL; Sun ZL
Int J Cardiol; 2006 Jun; 110(1):60-6. PubMed ID: 16242797
[TBL] [Abstract][Full Text] [Related]
19. Metalloproteinase inhibition ameliorates hypertension and prevents vascular dysfunction and remodeling in renovascular hypertensive rats.
Castro MM; Rizzi E; Figueiredo-Lopes L; Fernandes K; Bendhack LM; Pitol DL; Gerlach RF; Tanus-Santos JE
Atherosclerosis; 2008 Jun; 198(2):320-31. PubMed ID: 18054360
[TBL] [Abstract][Full Text] [Related]
20. Atorvastatin and sildenafil lower blood pressure and improve endothelial dysfunction, but only atorvastatin increases vascular stores of nitric oxide in hypertension.
Guimarães DA; Rizzi E; Ceron CS; Pinheiro LC; Gerlach RF; Tanus-Santos JE
Redox Biol; 2013; 1(1):578-85. PubMed ID: 24363994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
